← back to search

Gang Wang

Harbin Medical University · CN
🔎 Find collaborators in Pharmacology · Cognitive Neuroscience →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Pharmacology · Cognitive Neuroscience
Research interest
Research focused on Major depressive disorder and Depression (economics), with related work in Neuropsychology, Serotonin reuptake inhibitor, Neurocognitive. Notable publications include 'Association between residual symptoms and social functioning in patients with depression', 'Does early and late life depression differ in residual symptoms, functioning and quality of life among the first-episode major depressive patients', and 'Features of cognitive impairment and related risk factors in patients with major depressive disorder: A case-control study'.
h-index
citations
118
works
14
NIH funding
primary concept
email

Recent publications

Deciphering the Heterogeneity of Schizophrenia: A Multimodal and Multivariate Neuroimaging Framework for Unveiling Brain-Symptom Relationships and Underlying Subtypes
Schizophrenia Bulletin 2025cited by 2position: middledoi
A novel anti-acute lung injury mechanism of astilbin: inhibition of epithelial cells ferroptosis by targeting NRF2 activation via binding Val608 site of NRF2
Inflammation Research 2025cited by 1position: middledoi
Associations between age of onset and domain-specific cognitive deficits in major depressive disorder
Journal of Affective Disorders 2025cited by 0position: middledoi
Latent classes of symptom trajectories among major depressive disorder patients in China
Journal of Affective Disorders 2024cited by 5position: middledoi
Selective disrupted gray matter volume covariance of amygdala subregions in schizophrenia
Frontiers in Psychiatry 2024cited by 1position: middledoi
A multicenter, randomized, double-blind, duloxetine-controlled, non-inferiority trial of desvenlafaxine succinate extended-release in patients with major depressive disorder
Journal of Affective Disorders 2023cited by 7position: lastdoi
Sex differences in residual somatic symptoms in patients with first-episode depression after acute-phase treatment
BMC Psychiatry 2023cited by 5position: middledoi
Features of cognitive impairment and related risk factors in patients with major depressive disorder: A case-control study
Journal of Affective Disorders 2022cited by 16position: middledoi
Efficacy and safety of aripiprazole once-monthly versus oral aripiprazole in Chinese patients with acute schizophrenia: a multicenter, randomized, double-blind, non-inferiority study
Psychopharmacology 2022cited by 12position: lastdoi
Machine learning to predict clinical remission in depressed patients after acute phase selective serotonin reuptake inhibitor treatment
Journal of Affective Disorders 2021cited by 16position: middledoi
Neurocognitive profiles of patients with first-episode and recurrent depression: a cross-sectional comparative study from China
Journal of Affective Disorders 2021cited by 14position: middledoi
Association between residual symptoms and social functioning in patients with depression
Comprehensive Psychiatry 2020cited by 29position: middledoi
Does early and late life depression differ in residual symptoms, functioning and quality of life among the first-episode major depressive patients
Asian Journal of Psychiatry 2019cited by 19position: lastdoi
The residual physical symptoms in Chinese patients with major depressive disorder after acute treatment phase: a cross-sectional survey among eleven mental health centers
Chin J Psychiatry 2019cited by 2position: middledoi
Prescribing patterns of psychotropic medications and clinical features in patients with major depressive disorder with and without comorbid dysthymia in China
Asia-Pacific Psychiatry 2016cited by 1position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Xueyi Wang · Hebei Medical University7 papers (2019–2025)Hongjun Tian · Anhui Medical University6 papers (2021–2025)Kerang Zhang · Shanxi Medical University6 papers (2021–2025)Jing Wei · Fudan University5 papers (2021–2025)Gang Zhu · Harbin Medical University5 papers (2021–2025)Xin Yu · Kunming University of Science and Technology5 papers (2021–2025)Jian Hu · Nanchang University5 papers (2016–2023)Tianmei Si · Wenzhou Medical University5 papers (2016–2025)Qiaoling Chen · Anhui Medical University5 papers (2021–2025)Nan Zhang · Stanford University5 papers (2021–2025)Wenyuan Wu · Nanjing University of Chinese Medicine4 papers (2019–2023)Tiebang Liu · Anhui Medical University4 papers (2019–2022)Yiru Fang · Shanghai Mental Health Center4 papers (2016–2020)Ning Zhang · Northeastern University3 papers (2019–2020)Fu‐Jun Jia · Guangdong Academy of Medical Sciences3 papers (2019–2020)Chengge Gao · Xi'an Jiaotong University3 papers (2019–2020) · 2 papers (2024–2025)Chuan Shi · Chinese PLA General Hospital2 papers (2021–2025)Zhen Zhao · Tianjin Medical University General Hospital2 papers (2024–2025)Wei Liu · Hebei Medical University2 papers (2024–2025)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Pharmacology · Cognitive Neuroscience →